NT Growth Factor Receptor Market
Global NT Growth Factor Receptor Market Size, Share & Trends Analysis Report By Type (AZD-7451, Larotrectinib, DS-6051, LM-22B10, and Others), and By Application (Breast Cancer, Brain Cancer, Solid Tumor, Colon Cancer, Fibrosarcoma, and Others) Forecast 2022-2028 Update Available - Forecast 2024-2030
The global NT growth factor receptor market is anticipated to grow at a significant CAGR during the forecast period. The major factors for the market growth are the increasing prevalence of cancer globally. According to the National Cancer Institute, cancer is considered the leading cause of death across the globe. In 2020, around 1,806,590 new cases of cancer were been diagnosed in the US. Additionally, as per WHO by 2040, the number of new cancer patients is expected to rise to 29.5 million and the number of deaths related to cancer will reach 16.4 million globally. The most common cancer among them is breast cancer, lung cancer, prostate cancer, colon cancer, and bladder cancer. The costs are likely to increase as new and more expensive treatments are adopted as standards of care. Hence, the rising prevalence of this disease is anticipated to propel the growth of the global NT growth factor receptor market in the forecast period.
Impact of COVID-19 Pandemic on Global NT Growth Factor Receptor Market
During the COVID-19 pandemic, cancer treatment such as chemotherapy that is taken after surgical cancer removal usually weakens the patient’s immune system. This means that the patients have more chances to get affected by the COVID-19 due to the low immunity system. So, the demand for NT growth factor receptors was high, though the supply chain was disrupted due to several government guidelines.
Segmental Outlook
The global NT growth factor receptor market is segmented based on the type and application. Based on the type, the market is segmented into AZD-7451, larotrectinib, DS-6051, LM-22B10, and others. Based on the application, the market is sub-segmented into breast cancer, brain cancer, solid tumor, colon cancer, fibrosarcoma, and others. Amongst the type, larotrectinib is anticipated to propel the growth of the market over the forecast period.
Global NT growth factor receptor Market Share by Type, 2022 (%)
The Larotrectinib is Anticipated to Hold a Prominent Share in the Global NT Growth Factor Receptor Market
Larotrectinib is anticipated to hold the major share in the global NT growth factor receptor market. Larotrectinib is a tyrosine kinase inhibitor that is currently used for the treatment of cancer with solid tumors. Larotrectinib is already approved by the FDA based on the overall response rate and duration of response. Additionally, a continuation of support for larotrectinib may be contingent upon the verification and description of clinical benefits. The main advantage of using larotrectinib to treat cancer is that it works by slowing or stopping the growth of cancer cells. The increased advantages of larotrectinib over others and the recent approval by the FDA of larotrectinib as the drug approved for the treatment of adults and children patients with solid tumors is boosting the segment growth.
Regional Outlooks
The global NT growth factor receptor market is further segmented based on geography including North America (the US, and Canada), Europe (Italy, Spain, Germany, France, and Others), Asia-Pacific (India, China, Japan, and Others), and the Rest of the World (the Middle East &Africa, and Latin America).
Global NT Growth Factor Receptor Market Growth, by Region 2022-2028
The North American Region is Estimated to Hold the Major Share in the Global NT Growth Factor Receptor Market
North America is anticipated to hold the major share in the global NT growth factor receptor market. The increased prevalence of cancer in this region is also boosting the market growth. According to the Cancer Atlas, an estimation of about 1.9 million new cancers cases were registered in North America, and 693,000 deaths were estimated by the end of 2018. Additionally, the awareness among the population in this region, and the adoption of new treatment procedures to treat cancer patients is boosting the North American NT growth factor receptor market.
Market Players Outlook
The major companies serving the global NT growth factor receptor market include AstraZeneca, Daiichi Sankyo Co. Ltd., HANDOK Inc., Ignyta Inc., Loxo Oncology, and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers & acquisitions, new product launches, FDA approval, research, and development of new drugs to stay competitive in the market. For instance, in December 2020, AstraZeneca Plc set forth that Tagrisso (osimertinib) is approved by the FDA in the US which is used for the treatment of adult patients with early-stage epidermal growth factor receptor-mutated (EGFRm) non-small cell lung cancer (NSCLC) after tumor resection.
The Report Covers
- Market value data analysis of 2021 and forecast to 2028.
- Annualized market revenues ($ million) for each market segment.
- Country-wise analysis of major geographical regions.
- Key companies operating in the global NT growth factor receptor market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
- Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
- Analysis of market entry and market expansion strategies.
- Competitive strategies by identifying ‘who-stands-where’ in the market.
1. Report Summary
- Current Industry Analysis and Growth Potential Outlook
- Impact of COVID-19 on The Global NT Growth Factor Receptor Market
- Recovery Scenario of Global NT Growth Factor Receptor Market
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. BY Region
2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
3. Competitive Landscape
3.1. Key Company Analysis
3.1.1. Overview
3.1.2. Financial Analysis
3.1.3. SWOT Analysis
3.1.4. Recent Developments
3.2. Key Strategy Analysis
3.3. Impact of Covid-19 on Key Players
4. Market Segmentation
4.1. Global NT Growth Factor Receptor Market by Type
4.1.1. AZD-7451
4.1.2. Larotrectinib
4.1.3. DS-6051
4.1.4. LM-22B10
4.1.5. Others
4.2. Global NT Growth Factor Receptor Market by Application
4.2.1. Breast cancer
4.2.2. Brain cancer
4.2.3. Solid tumor
4.2.4. Colon cancer
4.2.5. Fibrosarcoma
4.2.6. Others
5. Regional Analysis
5.1. North America
5.1.1. United States
5.1.2. Canada
5.2. Europe
5.2.1. UK
5.2.2. Germany
5.2.3. Italy
5.2.4. Spain
5.2.5. France
5.2.6. Rest of Europe
5.3. Asia-Pacific
5.3.1. China
5.3.2. India
5.3.3. Japan
5.3.4. Rest of Asia-Pacific
5.4. Rest of the World
6. Company Profiles
6.1. AstraZeneca
6.2. Daiichi Sankyo Co. Ltd.
6.3. HANDOK Inc.
6.4. Ignyta Inc.
6.5. Loxo Oncology
6.6. NETRIS Pharma
6.7. Plexxikon
1. GLOBAL NT GROWTH FACTOR RECEPTOR MARKET RESEARCH AND ANALYSIS BY TYPE, 2021 - 2028 ($ MILLION)
2. GLOBAL AZD-7451 NT GROWTH FACTOR RECEPTOR MARKET RESEARCH AND ANALYSIS BY REGION, 2021 - 2028 ($ MILLION)
3. GLOBAL LAROTRECTINIB NT GROWTH FACTOR RECEPTOR MARKET RESEARCH AND ANALYSIS BY REGION, 2021 - 2028 ($ MILLION)
4. GLOBAL DS-6051 NT GROWTH FACTOR RECEPTOR MARKET RESEARCH AND ANALYSIS BY REGION, 2021 - 2028 ($ MILLION)
5. GLOBAL LM-22B10 NT GROWTH FACTOR RECEPTOR MARKET RESEARCH AND ANALYSIS BY REGION, 2021 - 2028 ($ MILLION)
6. GLOBAL OTHERS NT GROWTH FACTOR RECEPTOR MARKET RESEARCH AND ANALYSIS BY REGION, 2021 - 2028 ($ MILLION)
7. GLOBAL NT GROWTH FACTOR RECEPTOR MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021 - 2028 ($ MILLION)
8. GLOBAL BREAST CANCER NT GROWTH FACTOR RECEPTOR MARKET RESEARCH AND ANALYSIS BY REGION, 2021 - 2028 ($ MILLION)
9. GLOBAL BRAIN CANCER NT GROWTH FACTOR RECEPTOR MARKET RESEARCH AND ANALYSIS BY REGION, 2021 - 2028 ($ MILLION)
10. GLOBAL SOLID TUMOR NT GROWTH FACTOR RECEPTOR MARKET RESEARCH AND ANALYSIS BY REGION, 2021 - 2028 ($ MILLION)
11. GLOBAL COLON CANCER NT GROWTH FACTOR RECEPTOR MARKET RESEARCH AND ANALYSIS BY REGION, 2021 - 2028 ($ MILLION)
12. GLOBAL FIBROSARCOMA NT GROWTH FACTOR RECEPTOR MARKET RESEARCH AND ANALYSIS BY REGION, 2021 - 2028 ($ MILLION)
13. GLOBAL OTHERS NT GROWTH FACTOR RECEPTOR MARKET RESEARCH AND ANALYSIS BY REGION, 2021 - 2028 ($ MILLION)
14. GLOBAL NT GROWTH FACTOR RECEPTOR MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2021 - 2028 ($ MILLION)
15. NORTH AMERICAN NT GROWTH FACTOR RECEPTOR MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021 - 2028 ($ MILLION)
16. NORTH AMERICAN NT GROWTH FACTOR RECEPTOR MARKET RESEARCH AND ANALYSIS BY TYPE, 2021 - 2028 ($ MILLION)
17. NORTH AMERICAN NT GROWTH FACTOR RECEPTOR MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021 - 2028 ($ MILLION)
18. EUROPEAN NT GROWTH FACTOR RECEPTOR MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021 - 2028 ($ MILLION)
19. EUROPEAN NT GROWTH FACTOR RECEPTOR MARKET RESEARCH AND ANALYSIS BY TYPE, 2021 - 2028 ($ MILLION)
20. EUROPEAN NT GROWTH FACTOR RECEPTOR MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021 - 2028 ($ MILLION)
21. ASIA-PACIFIC NT GROWTH FACTOR RECEPTOR MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021 - 2028 ($ MILLION)
22. ASIA-PACIFIC NT GROWTH FACTOR RECEPTOR MARKET RESEARCH AND ANALYSIS BY TYPE, 2021 - 2028 ($ MILLION)
23. ASIA-PACIFIC NT GROWTH FACTOR RECEPTOR MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021 - 2028 ($ MILLION)
24. REST OF THE WORLD NT GROWTH FACTOR RECEPTOR MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021 - 2028 ($ MILLION)
25. REST OF THE WORLD NT GROWTH FACTOR RECEPTOR MARKET RESEARCH AND ANALYSIS BY TYPE, 2021 - 2028 ($ MILLION)
26. REST OF THE WORLD NT GROWTH FACTOR RECEPTOR MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021 - 2028 ($ MILLION)
1. IMPACT OF COVID-19 ON GLOBAL NT GROWTH FACTOR RECEPTOR MARKET, 2021 – 2028 ($ MILLION)
2. IMPACT OF COVID-19 ON GLOBAL NT GROWTH FACTOR RECEPTOR MARKET BY SEGMENT, 2021 – 2028 ($ MILLION)
3. RECOVERY OF GLOBAL NT GROWTH FACTOR RECEPTOR MARKET, 2022-2028 (%)
4. GLOBAL NT GROWTH FACTOR RECEPTOR MARKET SHARE BY TYPE, 2021 VS 2028 (%)
5. GLOBAL AZD-7451 NT GROWTH FACTOR RECEPTOR MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
6. GLOBAL LAROTRECTINIB NT GROWTH FACTOR RECEPTOR MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
7. GLOBAL DS-6051 NT GROWTH FACTOR RECEPTOR MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
8. GLOBAL LM-22B10 NT GROWTH FACTOR RECEPTOR MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
9. GLOBAL OTHERS NT GROWTH FACTOR RECEPTOR MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
10. GLOBAL NT GROWTH FACTOR RECEPTOR MARKET SHARE BY APPLICATION, 2021 VS 2028 (%)
11. GLOBAL BREAST CANCER NT GROWTH FACTOR RECEPTOR MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
12. GLOBAL BRAIN CANCER NT GROWTH FACTOR RECEPTOR MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
13. GLOBAL SOLID TUMOR NT GROWTH FACTOR RECEPTOR MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
14. GLOBAL COLON CANCER NT GROWTH FACTOR RECEPTOR MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
15. GLOBAL FIBROSARCOMA NT GROWTH FACTOR RECEPTOR MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
16. GLOBAL OTHERS NT GROWTH FACTOR RECEPTOR MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
17. GLOBAL NT GROWTH FACTOR RECEPTOR MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
18. US NT GROWTH FACTOR RECEPTOR MARKET SIZE, 2021 – 2028 ($ MILLION)
19. CANADA NT GROWTH FACTOR RECEPTOR MARKET SIZE, 2021 – 2028 ($ MILLION)
20. UK NT GROWTH FACTOR RECEPTOR MARKET SIZE, 2021 – 2028 ($ MILLION)
21. FRANCE NT GROWTH FACTOR RECEPTOR MARKET SIZE, 2021 – 2028 ($ MILLION)
22. GERMANY NT GROWTH FACTOR RECEPTOR MARKET SIZE, 2021 – 2028 ($ MILLION)
23. ITALY NT GROWTH FACTOR RECEPTOR MARKET SIZE, 2021 – 2028 ($ MILLION)
24. SPAIN NT GROWTH FACTOR RECEPTOR MARKET SIZE, 2021 – 2028 ($ MILLION)
25. REST OF EUROPE NT GROWTH FACTOR RECEPTOR MARKET SIZE, 2021 – 2028 ($ MILLION)
26. INDIA NT GROWTH FACTOR RECEPTOR MARKET SIZE, 2021 – 2028 ($ MILLION)
27. CHINA NT GROWTH FACTOR RECEPTOR MARKET SIZE, 2021 – 2028 ($ MILLION)
28. JAPAN NT GROWTH FACTOR RECEPTOR MARKET SIZE, 2021 – 2028 ($ MILLION)
29. REST OF ASIA-PACIFIC NT GROWTH FACTOR RECEPTOR MARKET SIZE, 2021 – 2028 ($ MILLION)
30. REST OF THE WORLD NT GROWTH FACTOR RECEPTOR MARKET SIZE, 2021 – 2028 ($ MILLION)
